Drug Price Transparency Could Help Control Costs
February 23, 2017
Position statement supporting House Bill 666 Given before the Senate Finance Committee Skyrocketing costs for prescription drugs are a major factor driving up the costs of health care and insurance for everyone. Providing some basic transparency around those cost increases,